These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2084299)

  • 1. [Thrombolytic therapy and angioplasty in myocardial infarction-- progress in the 1980s].
    Twardowski RM
    Kardiol Pol; 1990; 33(6):345-50. PubMed ID: 2084299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasminogen activators as thrombolytic agents in myocardial infarction].
    Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of thrombolytic therapy in acute myocardial infarction.
    Dutta AL; Mandal M
    J Indian Med Assoc; 1991 Nov; 89(11):322-4. PubMed ID: 1787323
    [No Abstract]   [Full Text] [Related]  

  • 4. Streptokinase...never again.
    van de Werf F
    Eur Heart J; 1999 Sep; 20(17):1215. PubMed ID: 10454969
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombolysis (Consensus about post-myocardial infarction treatment)].
    Arq Bras Cardiol; 1995 Mar; 64(3):271-80. PubMed ID: 7487519
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolytic therapy in acute myocardial infarction--update].
    Jaffe R; Gotsman MS; Zahger D
    Harefuah; 1996 Jun; 130(11):751-7. PubMed ID: 8794679
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic occlusion of the left main coronary artery during stenting: successful management with intracoronary urokinase and autoperfusion balloon.
    Gambhir DS; Trehan V; Sudha R; Kaul UA; Arora R
    Indian Heart J; 1996; 48(3):273-5. PubMed ID: 8755014
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD; Bronskill S; Goel V
    Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
    [No Abstract]   [Full Text] [Related]  

  • 10. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    de Boer MJ; van Hout BA; Liem AL; Suryapranata H; Hoorntje JC; Zijlstra F
    Am J Cardiol; 1995 Oct; 76(11):830-3. PubMed ID: 7572666
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis from P values to public health.
    Brophy JM
    Can J Cardiol; 1994 Dec; 10(10):997-9. PubMed ID: 7994669
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute myocardial infarction: in which patients should primary percutaneous transluminal coronary angioplasty be preferred to thrombolysis?
    Topol EJ
    Cardiologia; 1996 Sep; 41(9):843-7. PubMed ID: 8940780
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients].
    Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary angioplasty, instead of thrombolysis, for all patients with acute ST-elevation myocardial infarction?
    Steffenino G; Dellavalle A; La Scala E; Baralis G
    Ital Heart J; 2003 Apr; 4(4):219-24. PubMed ID: 12784772
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Kharash LM; Goldkhammer EI
    Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction].
    Pereira H
    Rev Port Cardiol; 2000 Mar; 19(3):379-80. PubMed ID: 10804785
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary thrombolysis: hemorrhagic complications.
    Hirsh J
    Can J Cardiol; 1993; 9(6):505-11. PubMed ID: 8221344
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary angioplasty compared with thrombolytic therapy for acute myocardial infarction.
    Yusuf S; Pogue J
    JAMA; 1997 Dec; 278(23):2110-1. PubMed ID: 9403429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.